{
  "id": 20372651,
  "title": "Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO",
  "url": "https://urgent.news/2026/11/17/candidate-vaccine-by-sii-oxford-varsity-to-join-ebola-trial-who",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-17T02:08:30.000Z",
  "source": {
    "name": "Hindustan Times",
    "slug": "hindustan-times",
    "url": "https://www.hindustantimes.com/india-news/candidate-vaccine-by-sii-oxford-varsity-to-join-ebola-trialwho-101794854816730.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}